InvestSMART

Clever Culture Systems Limited (ASX:CC5)

ALERT: Price-sensitive ASX Announcement for CC5
Current share price for CC5 : $0.017 -0.001 (-2.94%)+
Release
30 Jul 2026 9:39AM
Price at Release
$0.017
Full Release
download
Summary
Clever Culture Systems Ltd, an Australian medical technology company, published their quarterly cashflow report for the period ending 30 June 2026. The company, specializing in microbiology automation with their APAS® Independence system, reported a strengthened global customer base, particularly in the pharmaceutical sector, with eight major clients. They hold a cash balance of $1.7 million and anticipate $3.4 million in cash inflows in the next two quarters. Although the net cash from operating activities showed a deficit of $1.679 million, the company has raised $1.6 million in short-term debt to manage working capital. Entering FY27, Clever Culture Systems plans to expand sales, building on existing and new customer relationships.
Key Points
  • Clever Culture Systems Ltd (ASX: CC5) released their quarterly cashflow report for the quarter ended 30 June 2026.
  • The company focuses on microbiology automation using AI, with the APAS® Independence system being a key product.
  • They have expanded their global customer base, particularly in the pharmaceutical sector, doubling the number of large pharmaceutical clients to eight compared to FY25.
  • The company reports a cash balance of $1.7 million as of 30 June 2026, with expected cash inflows of $3.4 million in the upcoming quarters.
  • Net cash from operating activities was reported as -$1.679 million for the quarter.
  • They have secured short-term debt funding of $1.6 million, which is unsecured and intended to manage working capital during their sales expansion phase.
  • Clever Culture Systems Ltd is preparing for a sales expansion phase in FY27, leveraging existing and new customer opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.